dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

Starting soon · Phase 1/Phase 2

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to conduct a US Pilot study of dMD-002 as a peripheral nerve repair sheet in patients with cavernous nerve injury following radical prostatectomy. The study will determine which endpoints and timepoints will be used for the pivotal study.

Key facts

Study ID

NCT07564102

Run by

Mochida Medical USA, Inc.

People needed

30

Starts

2026-08-01

Expected to finish

2028-06-30

Last updated by the study team

2026-05-15

Who can join

Age: 40 and older, up to 74. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients diagnosed with prostate cancer.
• Patients scheduled to undergo a robot-assisted radical prostatectomy (including either bilateral-nerve sparing or unilateral-nerve sparing) for treatment of prostate cancer.
• etc.

You may not qualify if…

• Patients undergoing pre-surgery or post-surgery radiation therapy, hormone therapy, or anti-cancer therapy.
• Patients who have used a penile prosthesis implantation.
• Patients with a history of transurethral resection, laser therapy, microwave therapy, radiofrequency ablation, cryoablation, or other prostate surgery.
• etc.

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.